Glion AI Biotherapeutics

About

Q&A

What is Glion AI Biotherapeutics' primary sector?

Glion AI Biotherapeutics operates in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology.

When was Glion AI Biotherapeutics founded?

Glion AI Biotherapeutics was founded in May 2023.

What is the current employee count for Glion AI Biotherapeutics?

Glion AI Biotherapeutics has 1-10 employees.

What is the current funding stage of Glion AI Biotherapeutics?

Glion AI Biotherapeutics is currently in the Pre-Funding stage.

What technologies does Glion AI Biotherapeutics utilize?

Glion AI Biotherapeutics utilizes technologies such as Artificial Intelligence, Deep Learning, Machine Learning, Natural Language Processing, Simulation & Imaging, and Synthetic Data, applied to Biologicals, Molecules, Genes, and Cells.

What are the target customer segments for Glion AI Biotherapeutics?

Glion AI Biotherapeutics targets customers in the Healthcare & Life Sciences sector, specifically Healthcare and Life Sciences.

What is the product stage of Glion AI Biotherapeutics?

Glion AI Biotherapeutics is currently in the R&D product stage.

Where is Glion AI Biotherapeutics headquartered?

Glion AI Biotherapeutics is headquartered in Israel.

Team · 2

Ilan Sinai

Founder · Founder

LinkedIn ↗

Aviv De Morgan

Founder · founders

Sectors & technology

Highlights

Tags